Moolec Science (MLECW) Exchange Rate Effect (2022 - 2024)
Moolec Science (MLECW) posted Exchange Rate Effect of $2.3 million for Q4 2024, up 4643.32% sequentially from -$51552.0 in Q3 2024, and up 137.05% YoY from $988037.5 in Q1 2024.
Moolec Science (MLECW) Exchange Rate Effect (2022 - 2024) Analysis & Trends
Moolec Science has reported Exchange Rate Effect for 3 years, with the latest figure at $2.3 million in Q4 2024.
- Quarterly Exchange Rate Effect rose 137.05% year-over-year to $2.3 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$4.5 million (down 290.56% YoY) and the FY2025 annual result came in at -$4.9 million, up 28.08% from the prior year.
- Exchange Rate Effect advanced to $2.3 million in Q4 2024 per MLECW's latest filing, from -$51552.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $5.0 million in Q2 2023 and troughed at -$7.1 million in Q2 2024.
- A 3-year average of -$475416.7 and a median of -$551.5 in 2022 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 460947.93% in 2023, down 10195300.0% in 2023.
- Over 3 years, Exchange Rate Effect stood at -$62.0 in 2022, then plunged by 10195300.0% to -$6.3 million in 2023, then surged by 137.05% to $2.3 million in 2024.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $2.3 million, -$51552.0, and -$7.1 million for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Moolec Science | 8,617.72 | -1.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2.34 Mn |
| Dec 31, 2024 | 2.34 Mn |
| Sep 30, 2024 | -51,552.00 |
| Sep 30, 2024 | -51,552.00 |
| Jun 30, 2024 | -7.09 Mn |
| Jun 30, 2024 | -7.09 Mn |
| Mar 31, 2024 | 261,136.00 |
| Mar 31, 2024 | 261,136.00 |
| Dec 31, 2023 | -6.32 Mn |
| Dec 31, 2023 | -6.32 Mn |
| Sep 30, 2023 | 22,365.00 |
| Sep 30, 2023 | 22,365.00 |
| Jun 30, 2023 | 5.00 Mn |
| Jun 30, 2023 | 5.00 Mn |
| Mar 31, 2023 | 136,700.00 |
| Mar 31, 2023 | 136,700.00 |
| Dec 31, 2022 | -62.00 |
| Dec 31, 2022 | -62.00 |
| Sep 30, 2022 | -3,084.00 |
| Sep 30, 2022 | -3,084.00 |